(Q53506236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jan J Verschuuren

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Femke M P Zitman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Peter D Humphreys

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kay Greenshields

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Russell P Rother

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jaap J Plomp

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hugh J Willison

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Bart C Jacobs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

8 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

Pt 5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1197-1208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Anti-ganglioside antibodies alter presynaptic release and calcium influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

A clinical prognostic scoring system for Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

The immunopathogenesis of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

The Membrane Attack Complex of the Complement System Is Essential for Rapid Wallerian Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWM316

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWM316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18184663%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference